Viatris VTRS
NASDAQ VTRS
$16.46 -0.15 (-0.90%)
As of: Sep 9, 2026 · 3:09 PM EDT

Viatris (VTRS) Operating Income (2020 - 2026)

Viatris (VTRS) posted Operating Income of $6.3 million for Q2 2026, up 107.9% on a QoQ basis from -$79.7 million in Q1 2026, and down 97.3% year-over-year from $233.0 million in Q2 2025.

Analysis

Viatris (VTRS) Operating Income (2020 - 2026) Analysis & Trends

Viatris has reported Operating Income for 7 years, with the latest figure at $6.3 million in Q2 2026.

  • On a quarterly basis, Operating Income fell 97.3% year-over-year to $6.3 million in Q2 2026; TTM through Jun 2026 was -$87.3 million, a 96.65% increase from a year earlier, with the FY2025 full-year figure at -$2.7 billion, down 26467.33% from the prior year.
  • Operating Income was $6.3 million for Q2 2026 at Viatris, up from -$79.7 million in the prior quarter.
  • The five-year high for Operating Income was $707.4 million in Q1 2022, with the low at -$2.9 billion in Q1 2025.
  • Average Operating Income over 5 years is -$19.2 million, with a median of $191.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Operating Income soared 1247.91% in 2022, then tumbled 1513.54% in 2025.
  • Over 5 years, Operating Income stood at -$201.3 million in 2022, then plunged by 125.78% to -$454.5 million in 2023, then soared by 60.44% to -$179.8 million in 2024, then declined by 7.17% to -$192.7 million in 2025, then surged by 103.27% to $6.3 million in 2026.
  • The last three Operating Income figures came in at $6.3 million (Q2 2026), -$79.7 million (Q1 2026), and -$192.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Teva Pharmaceutical Industries 42.55 Bn 38.89 Bn 2.15 Bn -231.00 Mn
2 Viatris 19.15 Bn 18.26 Bn 1.46 Bn 6.30 Mn
3 Dr Reddys Laboratories 9.87 Bn 9.70 Bn 396.53 Mn 39.97 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.32 Bn 334.51 Mn 129.77 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 740.00 Mn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn -73.42 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 40.46 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 39.73 Mn
9 Fennec Pharmaceuticals 401.76 Mn 360.51 Mn 17.15 Mn 1.74 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.30 Mn
Mar 31, 2026 -79.70 Mn
Dec 31, 2025 -192.70 Mn
Sep 30, 2025 178.80 Mn
Jun 30, 2025 233.00 Mn
Mar 31, 2025 -2.88 Bn
Dec 31, 2024 -179.80 Mn
Sep 30, 2024 225.90 Mn
Jun 30, 2024 -239.90 Mn
Mar 31, 2024 203.90 Mn
Dec 31, 2023 -454.50 Mn
Sep 30, 2023 451.70 Mn
Jun 30, 2023 369.20 Mn
Mar 31, 2023 399.80 Mn
Dec 31, 2022 -201.30 Mn
Sep 30, 2022 560.10 Mn
Jun 30, 2022 548.70 Mn
Mar 31, 2022 707.40 Mn
Dec 31, 2021 -77.60 Mn
Sep 30, 2021 357.60 Mn